Lind Returns to the CancerX Moffitt Innovation Summit as Accelerator Alumni
Lind returned to the CancerX Accelerator Moffitt Innovation Summit in 2025, joining an Alumni Fireside Chat to share how an inaugural-cohort startup has scaled into enterprise health-system contracts and where clinician-guided AI trial screening goes next.
Lind returned to Moffitt Cancer Center for the CancerX Accelerator Moffitt Innovation Summit, the in-person flagship of the CancerX Accelerator program convening leading oncology startups, Champion Organizations, and federal partners.
As a member of the inaugural CancerX cohort, Lind was invited to take part in an Alumni Fireside Chat, highlighted as an alumnus that has gone on to secure enterprise contracts with Champion organizations, a proof point for the program’s role in creating commercial pathways for digital innovation in oncology. CEO and Founder Oggie Nikolic shared lessons from Lind’s journey from validation to health-system deployment and offered guidance to the 2025 cohort.
“CancerX gave Lind its earliest momentum. Coming back as alumni is an honor as we discuss how to help the next cohort leverage this ecosystem to convert ideas into tools that can help patients today, the shared goal of the CancerX program,” said Oggie Nikolic, CEO and Founder of Lind.
Additional Information: https://cancerx.health/blog/moffitt-day-2025